Frank Rimerman Advisors’s Boston Scientific BSX Stock Holding History

Frank Rimerman Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Sell	20,258 -279	-1%	-$22.3K	0.08%	197
2025 Q4	$1.96M	Buy	20,537 +344	+2%	+$33.7K	0.12%	129
2025 Q3	$1.97M	Buy	20,193 +90	+0.4%	+$9.32K	0.13%	126
2025 Q2	$2.16M	Sell	20,103 -989	-5%	-$100K	0.15%	114
2025 Q1	$2.13M	Buy	21,092 +521	+3%	+$52.5K	0.17%	101
2024 Q4	$1.84M	Buy	20,571 +299	+1%	+$26.3K	0.13%	116
2024 Q3	$1.7M	Buy	20,272 +114	+0.6%	+$8.99K	0.12%	134
2024 Q2	$1.55M	Buy	20,158 +20,091	+29,987%	+$1.47M	0.11%	145
2024 Q1	$4.59K	Hold	67	–	–	﹤0.01%	211
2023 Q4	$3.87K	Buy	+67	New	+$3.58K	﹤0.01%	213

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Frank Rimerman Advisors's BSX Position: Q1 2026 in Review

Frank Rimerman Advisors reduced its Boston Scientific (BSX) stake by 1.4% in Q1 2026, selling an estimated $22.3K and leaving 20,258 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #197.

Frank Rimerman Advisors first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.16M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Frank Rimerman Advisors held 20,258 shares of Boston Scientific worth $1.27M as of Q1 2026.
Frank Rimerman Advisors sold 279 Boston Scientific shares in Q1 2026, an estimated $22.3K.
Boston Scientific made up 0.08% of Frank Rimerman Advisors's portfolio in Q1 2026, its #197 holding.
Frank Rimerman Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Frank Rimerman Advisors's Boston Scientific position peaked at $2.16M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.